Quick Answer
EXOZYMES INC. reported Operating Income Loss of -$9.72 million for the year ending 2025.
- EXOZYMES INC. showed a decrease of -63.8% in Operating Income Loss from 2024 to 2025.
- This data is from EXOZYMES INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), EXOZYMES INC.'s Operating Income Loss has declined by 440.9%.
- Historical annual values: Fiscal year 2025: -$9.72 million | Fiscal year 2024: -$5.93 million | Fiscal year 2023: -$1.80 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: